DK1680088T3 - Smagsmaskeret formulering indeholdende clarithromycin - Google Patents

Smagsmaskeret formulering indeholdende clarithromycin

Info

Publication number
DK1680088T3
DK1680088T3 DK04790492T DK04790492T DK1680088T3 DK 1680088 T3 DK1680088 T3 DK 1680088T3 DK 04790492 T DK04790492 T DK 04790492T DK 04790492 T DK04790492 T DK 04790492T DK 1680088 T3 DK1680088 T3 DK 1680088T3
Authority
DK
Denmark
Prior art keywords
formulation containing
taste masked
masked formulation
containing clarithromycin
clarithromycin
Prior art date
Application number
DK04790492T
Other languages
Danish (da)
English (en)
Inventor
Indranil Nandi
Mintong Guo
Chad Michael Gassert
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/688,551 external-priority patent/US20050084540A1/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK1680088T3 publication Critical patent/DK1680088T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04790492T 2003-10-17 2004-10-15 Smagsmaskeret formulering indeholdende clarithromycin DK1680088T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/688,551 US20050084540A1 (en) 2003-10-17 2003-10-17 Taste masking antibiotic composition
US10/768,562 US8168228B2 (en) 2003-10-17 2004-01-30 Antibiotic clarithromycin micropellet compositions
PCT/EP2004/011653 WO2005039536A1 (en) 2003-10-17 2004-10-15 Antibiotic compositions

Publications (1)

Publication Number Publication Date
DK1680088T3 true DK1680088T3 (da) 2009-03-23

Family

ID=34527177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04790492T DK1680088T3 (da) 2003-10-17 2004-10-15 Smagsmaskeret formulering indeholdende clarithromycin

Country Status (19)

Country Link
US (2) US8168228B2 (de)
EP (1) EP1680088B1 (de)
JP (1) JP2007508351A (de)
CN (1) CN1893927A (de)
AR (1) AR046113A1 (de)
AT (1) ATE415948T1 (de)
AU (1) AU2004283463B2 (de)
BR (1) BRPI0415450A (de)
CA (1) CA2542238A1 (de)
DE (1) DE602004018175D1 (de)
DK (1) DK1680088T3 (de)
ES (1) ES2317061T3 (de)
HR (1) HRP20090124T3 (de)
PE (1) PE20050441A1 (de)
PL (1) PL1680088T3 (de)
PT (1) PT1680088E (de)
RU (1) RU2376980C2 (de)
SI (1) SI1680088T1 (de)
WO (1) WO2005039536A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
WO2011079282A1 (en) * 2009-12-23 2011-06-30 Vaxgene Corporation Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
US20130034609A1 (en) * 2010-02-09 2013-02-07 Agency For Science, Technology And Research Smart polymers functionalized hollow silica vesicles
EP2386297A1 (de) * 2010-04-28 2011-11-16 Roquette Frères Unverdauliches Polymer: Filmüberzüge auf Basis von acetylierter Stärke für Colon-Targeting
US8828426B2 (en) * 2011-06-07 2014-09-09 Zx Pharma, Llc Multiparticulate L-carnitine compositions and related methods
BR112013027484A8 (pt) * 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato
MX2011007675A (es) * 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
CN107125440A (zh) * 2016-02-29 2017-09-05 湖南晶天科技实业有限公司 一种饲料添加剂肠溶包衣单宁酸及其制备方法以及一种饲料
CN107960589A (zh) * 2016-10-20 2018-04-27 湖南晶天科技实业有限公司 一种抗菌添加剂壳寡糖醛席夫碱和应用
CN107960533A (zh) * 2016-10-20 2018-04-27 湖南晶天科技实业有限公司 一种氨基酸醛席夫碱饲料添加剂以及一种饲料
CN110075085A (zh) * 2019-05-17 2019-08-02 南京望知星医药科技有限公司 一种罗红霉素微囊及其制备方法
CN113116859B (zh) * 2021-04-12 2022-08-30 海南普利制药股份有限公司 阿奇霉素丸芯包衣制剂
CN113777329B (zh) * 2021-09-16 2023-07-18 何秋富 一种视黄醇结合蛋白测定试剂盒及其制备方法
EP4577195A1 (de) * 2022-08-24 2025-07-02 Otsuka Pharmaceutical Co., Ltd. Pharmazeutische zusammensetzung mit centanafadin
AU2024280278A1 (en) * 2023-05-31 2025-11-27 Takeda Pharmaceutical Company Limited Maribavir compositions and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3099711A (en) * 1961-06-02 1963-07-30 Data Presentations Inc Printing device
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
JPH05255120A (ja) * 1992-03-12 1993-10-05 Taisho Pharmaceut Co Ltd 苦み隠蔽製剤
TW271400B (de) 1992-07-30 1996-03-01 Pfizer
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
US6010718A (en) 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US6221402B1 (en) * 1997-11-20 2001-04-24 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物
US6096341A (en) 1998-10-30 2000-08-01 Pharma Pass Llc Delayed release tablet of bupropion hydrochloride
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
IN191239B (de) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6451345B1 (en) 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
BR0109544A (pt) 2000-03-28 2003-06-10 Biochemie Gmbh Partìculas granuladas com sabor ocultado
IN192748B (de) 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
JP3211824B1 (ja) * 2000-10-26 2001-09-25 味の素株式会社 分岐鎖アミノ酸含有医薬用顆粒製剤とその製造方法
ES2195727B1 (es) 2001-07-05 2005-03-01 Ercros Industrial, S.A. Un procedimiento para la obtencion de claritromicina.
US20030099711A1 (en) 2001-08-29 2003-05-29 David Meadows Sustained release preparations
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
US6642276B2 (en) 2001-10-01 2003-11-04 M/S Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
AU2003215671A1 (en) * 2002-03-22 2003-10-08 Cilag Ag Sustained release formulation of tramadol
US7790215B2 (en) * 2002-03-26 2010-09-07 Purdue Pharma Lp Sustained-release gel coated compositions
EP1492507A2 (de) 2002-04-03 2005-01-05 Ranbaxy Laboratories, Ltd. Clarithromycinformulierungen mit verbesserter bioverfügbarkeit
US20070167380A1 (en) 2002-04-03 2007-07-19 Rahul Dabre Taste masked compositions of erythromycin a and derivatives thereof
TW200306868A (en) * 2002-05-22 2003-12-01 Shionogi & Co Composition of hardly soluble medicine with improved solubility

Also Published As

Publication number Publication date
PE20050441A1 (es) 2005-08-02
JP2007508351A (ja) 2007-04-05
ES2317061T3 (es) 2009-04-16
AR046113A1 (es) 2005-11-23
EP1680088B1 (de) 2008-12-03
WO2005039536A1 (en) 2005-05-06
US20070134344A1 (en) 2007-06-14
US20050084541A1 (en) 2005-04-21
BRPI0415450A (pt) 2006-12-19
PT1680088E (pt) 2009-01-30
RU2376980C2 (ru) 2009-12-27
ATE415948T1 (de) 2008-12-15
HRP20090124T3 (en) 2009-04-30
AU2004283463A1 (en) 2005-05-06
EP1680088A1 (de) 2006-07-19
SI1680088T1 (sl) 2009-08-31
CN1893927A (zh) 2007-01-10
AU2004283463B2 (en) 2007-12-20
RU2006116622A (ru) 2007-12-10
CA2542238A1 (en) 2005-05-06
PL1680088T3 (pl) 2009-06-30
US8168228B2 (en) 2012-05-01
DE602004018175D1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
ATE363895T1 (de) Zubereitungen enthaltend sucralose
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE352550T1 (de) Chinazolinderivate
DK1682493T3 (da) Amidoacetonitrilderivater
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
DK1680088T3 (da) Smagsmaskeret formulering indeholdende clarithromycin
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
DE502004002283D1 (de) Pasteurisierungsanlage
UY3355Q (es) Caramelo
FI20031004A0 (fi) Uusi syötävä koostumus
ATE449064T1 (de) Amidoacetonitrilderivate
IS8045A (is) Púrín-6-ón-afleiður
NO20032330L (no) Plugg
DE502004000456D1 (de) Ventilsteuerung
DK1638984T3 (da) Avermectin B1-monosaccharidderivater
UA9331S (uk) Цукерка
ITMI20041500A1 (it) Caramella
DOS2003000726S (es) Confiteria
UA9343S (uk) Шоколадний виріб
UA8548S (uk) Шоколадний виріб
UA9342S (uk) Шоколадний виріб
ITVA20030018U1 (it) Dama di cioccolato
SE0300904D0 (sv) Cocoschokladkaka
GB0308682D0 (en) Thermometer